PhD Matthew Chin successfully defends Viva

04 February 2020

Congratulations to the now Dr Matthew Chin for successfully defending his PhD on Designing Platforms to Biophysically Regulate T Cell Activation.

Supervised by CNIE Director, Professor Marc-Olivier Coppens, Professor of Regenerative Medicine Technology, Richard Day, and Dr Eileen Gentleman (Craniofacial and Regenerative Biology at King's College London), Matthew used the CNIE's nature-inspired engineering methodology to develop a platform for cancer immunotherapy, combining a wide range of techniques, from mechanobiology, nano patterning, materials science, microfluidics and process intensification to systems engineering.

PhD Matthew Chin successfully defends Viva